Cystic Fibrosis and Common Genetic Diseases

Cystic fibrosis is a life-limiting autosomal recessive disease caused by mutations in the CFTR gene, which encodes a chloride channel; its dysfunction leads to thick secretions that damage the lungs, pancreas, and other organs. It is the most common life-shortening inherited disease in many populations of European ancestry and serves here as the principal example of a common single-gene chronic disease of childhood.

Definition

Cystic fibrosis is an autosomal recessive multisystem disease caused by mutations in the gene encoding the cystic fibrosis transmembrane conductance regulator (CFTR), a chloride channel whose dysfunction produces abnormally viscous secretions affecting the airways, pancreas, intestine, and other exocrine organs.

Scope

This entry covers cystic fibrosis as a model monogenic chronic systemic disease: the CFTR gene defect, the resulting multi-organ pathophysiology, its inheritance and epidemiology, and the historical arc from gene discovery to mutation-targeted therapy. It introduces, but does not catalogue, the broader category of common genetic diseases of childhood, and cross-links to dedicated genetic-disease entries. It is reference-educational and does not provide treatment guidance.

Core questions

• How do CFTR gene mutations produce a multi-organ disease?
• Why is cystic fibrosis inherited in an autosomal recessive pattern?
• How does the disease illustrate the principles shared by common single-gene disorders?
• How did identifying the causal gene change the understanding and treatment of the disease?

Key concepts

• CFTR gene and chloride channel
• Autosomal recessive inheritance
• Genotype-phenotype relationship
• Defective ion transport and viscous secretions
• Multi-organ exocrine involvement
• Newborn screening
• CFTR modulator therapy

Mechanisms

Cystic fibrosis is caused by mutations in the CFTR gene, which encodes a cyclic-AMP-regulated chloride channel at the apical surface of epithelial cells. Loss or impairment of CFTR function disrupts transepithelial ion and water transport, producing dehydrated, viscous secretions. In the airways this impairs mucociliary clearance and leads to chronic infection and progressive lung damage; in the pancreas it obstructs ducts and causes exocrine insufficiency; and similar processes affect the intestine, liver, and reproductive tract. Because two defective gene copies are required, the disease follows autosomal recessive inheritance (Elborn, 2016; Riordan et al., 1989).

Clinical relevance

Cystic fibrosis is the prototypical common single-gene chronic disease of childhood, requiring lifelong multi-organ management and illustrating how a single molecular defect produces systemic illness. Survival has improved markedly over decades, turning a once-fatal childhood disease into a chronic condition extending well into adulthood. This entry describes the disease conceptually and is not a basis for individual diagnostic or treatment decisions.

Epidemiology

Cystic fibrosis is among the most common life-limiting autosomal recessive diseases in populations of European ancestry, with a lower reported frequency in other ancestral groups, and is increasingly identified through newborn screening (Elborn, 2016). The carrier frequency is appreciable in affected populations, consistent with its recessive inheritance.

Evidence & guidelines

The pathophysiology and clinical framing summarised here draw on a major narrative review (Elborn, 2016); the molecular basis rests on the identification and cloning of the CFTR gene (Riordan et al., 1989); and the principle of mutation-targeted treatment is exemplified by the trial of a CFTR potentiator in patients carrying the G551D mutation (Ramsey et al., 2011). Specific therapeutic regimens are governed by current consensus guidance, which this reference entry does not reproduce.

History

Cystic fibrosis was delineated as a distinct disease in the 1930s, when Dorothy Andersen described the characteristic pancreatic changes. A major turning point came in 1989 with the identification and cloning of the CFTR gene, which revealed the molecular cause (Riordan et al., 1989). Decades later, drugs that directly target the defective CFTR protein - beginning with a potentiator effective in the G551D mutation - opened an era of mutation-specific therapy (Ramsey et al., 2011).

Seminal works

• elborn-2016
• riordan-1989
• ramsey-2011

Frequently asked questions

Why does cystic fibrosis affect so many different organs?

The CFTR protein is a chloride channel present in epithelial cells throughout the body, so its dysfunction disrupts secretions in the airways, pancreas, intestine, liver, and reproductive tract, producing a multi-organ disease from a single gene defect.

What does it mean that cystic fibrosis is autosomal recessive?

A child develops cystic fibrosis only when both copies of the CFTR gene carry disease-causing mutations; people with one altered copy are typically healthy carriers.